<?xml version="1.0" encoding="UTF-8"?>
<fig fig-type="Figure" xml:lang="en" specific-use="collapsible" id="emmm201910938-fig-0001ev" orientation="portrait" position="float">
 <label>Figure EV1</label>
 <caption>
  <title>Serum antibody responses against the 
   <styled-content style="fixed-case" toggle="no">AAV</styled-content> vector capsid and 
   <styled-content style="fixed-case" toggle="no">PR</styled-content>8‐specific IgA
  </title>
  <p>
   <list list-type="alpha-upper" id="emmm201910938-list-0008">
    <list-item>
     <p>Total IgG ELISA titer induction over vaccination period against AAV9‐vector capsids in pooled sera (AAV‐HA, ‐cHA, ‐GFP, WIV 
      <italic>n</italic> = 18; AAV‐NP 
      <italic>n</italic> = 11; AAV‐HL, ‐mHL1, ‐mHL2 
      <italic>n</italic> = 7 mice per group) at indicated time points.
     </p>
    </list-item>
    <list-item>
     <p>AAV9‐vector‐neutralizing antibody titers in pooled pre‐challenge sera (AAV‐HA, ‐cHA, ‐GFP, WIV 
      <italic>n</italic> = 18; AAV‐NP 
      <italic>n</italic> = 11; AAV‐HL, ‐mHL1, ‐mHL2 
      <italic>n</italic> = 7 mice per group, technical duplicates). Dotted line indicates the limit of detection (LOD) at a dilution of 1:100. Mean ± SD.
     </p>
    </list-item>
    <list-item>
     <p>Regression analysis of total AAV9‐vector IgG ELISA titers and MN
      <sub>50</sub> titers. Coefficient of correlation (
      <italic>r</italic>
      <sup>2</sup>) and 
      <italic>P</italic>‐value are shown.
     </p>
    </list-item>
    <list-item>
     <p>Total IgG ELISA titers expressed as AUC against homologous Cal/7/9 virus in pre‐challenge serum pools (AAV‐HA, ‐cHA, ‐GFP, WIV 
      <italic>n</italic> = 18; AAV‐NP 
      <italic>n</italic> = 11; AAV‐HL, ‐mHL1, ‐mHL2 
      <italic>n</italic> = 7 mice per group, technical duplicates) of the indicated vaccine groups. Mean ± SD.
     </p>
    </list-item>
    <list-item>
     <p>Immunofluorescence microscopy staining of MDCKII cells 48 h after transfection with pAAV plasmids expressing the indicated constructs
      <sub>.</sub> Cells were fixed, permeabilized, and stained with the indicated mouse pre‐challenge serum pools or with anti‐V5‐tag antibody groups (
      <italic>n</italic> = 2, technical duplicates) (bar, 50 μm).
     </p>
    </list-item>
    <list-item>
     <p>Immunoblot analysis with lysates obtained from 293T 48 h after transfection with pAAV plasmids expressing the indicated constructs. Immunoblot was performed with the indicated pre‐challenge mouse serum pools (top, AAV‐HA 
      <italic>n</italic> = 18, AAV‐HL, ‐mHL1, ‐mHL2 
      <italic>n</italic> = 7 mice per group). Hereafter, membranes were stripped and stained with anti‐V5‐tag antibody (bottom). Position of detected protein bands is indicated to the right (bottom).
     </p>
    </list-item>
    <list-item>
     <p>Immunofluorescence microscopy staining of MCDKII cells 24 h after transfection with wild‐type Cal/7/9 NP or HA and mHL1 plasmids with pre‐challenge serum from AAV‐NP or AAV‐mHL1 + NP immunization groups (
      <italic>n</italic> = 2, technical duplicates) (bar, 50 μm).
     </p>
    </list-item>
    <list-item>
     <p>IgA ELISA titers against Cal/7/9 or PR8 virus in pooled pre‐challenge sera (AAV‐HA, ‐cHA, ‐GFP, WIV 
      <italic>n</italic> = 18; AAV‐NP 
      <italic>n</italic> = 11 mice per group, technical duplicates). Mean ± SD.
     </p>
    </list-item>
    <list-item>
     <p>IgA ELISA titers in post‐challenge lung homogenates of individual mice of the Cal/7/9 and PR8 low‐dose challenge groups of the indicated vaccine groups against PR8. Statistical significance between vaccine groups was determined using Kruskal–Wallis test with Dunn's multiple comparison testing (**
      <italic>P</italic> &lt; 0.01, ***
      <italic>P</italic> &lt; 0.001). Lines indicate mean. ELISAs were done in technical duplicates.
     </p>
    </list-item>
   </list>
  </p>
  <p>
   <named-content content-type="attribution">Source data are available online for this figure.</named-content>
  </p>
 </caption>
 <graphic id="nlm-graphic-9" xlink:href="EMMM-12-e10938-g003" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
